Palatin Flags Going-Concern Risk as Cash Dwindles to $7.5M
PTN sits 53% above its 52-week low of $5.61 on light trading volume (0.3× avg).
Summary
Palatin Technologies reported a narrowed FY26 net loss of $8.4M, down from $17.3M, but issued a going-concern warning, stating substantial doubt exists about its ability to continue as a going concern. The company had only $7.5M in cash and cash equivalents as of June 30, with an operating burn of $13.5M, and noted that additional funding will be required to continue advancing development programs and fund operations. The $13.2M in collaboration revenue is non-recurring, so the improved loss may not be sustainable. The $18.5M raised in FY26 diluted holders, and similar raises are likely. This is a survival-risk situation for a preclinical biotech; the market will focus on financing urgency over the narrower loss.
At the time of this announcement, PTN was trading at $8.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18M. The 52-week trading range was $5.61 to $31.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.